They are commonly used in EGFR mutation therapy for non-small cell lung cancer (NSCLC) and metastatic colorectal cancer with EGFR overexpression.29 These targeted therapies can be used as monotherapy or in conjunction with additional treatment approaches, such radiation therapy or chemotherapy, based on the particular malignancy and its features. Here, EGFR is linked to non-small cell lung carcinoma.